SYK – Stryker Corporation
SYK — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
1.13
Margin Of Safety %
9
Put/Call OI Ratio
0.84
EPS Next Q Diff
-1.01
EPS Last/This Y
6.48
EPS This/Next Y
1.76
Price
327.43
Target Price
430.92
Analyst Recom
1.61
Performance Q
-7.7
Upside
-43.6%
Beta
0.92
Ticker: SYK
16 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | SYK | 386.72 | 0.71 | 0.18 | 23428 |
| 2026-03-04 | SYK | 381.89 | 0.71 | 1.04 | 23600 |
| 2026-03-05 | SYK | 370.63 | 0.71 | 1.11 | 23623 |
| 2026-03-09 | SYK | 366.02 | 0.71 | 0.58 | 23670 |
| 2026-03-10 | SYK | 358.65 | 0.72 | 0.32 | 23727 |
| 2026-03-11 | SYK | 345.74 | 0.71 | 4.49 | 23856 |
| 2026-03-12 | SYK | 337.12 | 0.85 | 1.70 | 26365 |
| 2026-03-17 | SYK | 349.14 | 0.90 | 0.69 | 28987 |
| 2026-03-18 | SYK | 345.81 | 0.90 | 4.26 | 29149 |
| 2026-03-19 | SYK | 339.75 | 0.93 | 1.30 | 29775 |
| 2026-03-20 | SYK | 335.82 | 0.92 | 1.28 | 29893 |
| 2026-03-23 | SYK | 332.62 | 0.78 | 0.44 | 21243 |
| 2026-03-24 | SYK | 328.53 | 0.76 | 1.91 | 22134 |
| 2026-03-25 | SYK | 327.55 | 0.79 | 2.78 | 22572 |
| 2026-03-26 | SYK | 332.79 | 0.85 | 0.50 | 23677 |
| 2026-03-27 | SYK | 327.45 | 0.84 | 0.48 | 24074 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
16 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | SYK | 387.48 | 5.5 | 1787.2 | 14.97 |
| 2026-03-02 | SYK | 387.05 | 5.5 | 1255.1 | 14.97 |
| 2026-03-03 | SYK | 384.68 | 5.5 | 1225.6 | 14.97 |
| 2026-03-04 | SYK | 381.92 | 5.5 | 1220.2 | 14.97 |
| 2026-03-05 | SYK | 370.62 | 5.5 | 1087.0 | 14.97 |
| 2026-03-06 | SYK | 364.55 | 5.5 | 1164.5 | 14.97 |
| 2026-03-09 | SYK | 365.99 | 5.5 | 1284.4 | 14.97 |
| 2026-03-10 | SYK | 358.66 | 5.5 | 1144.5 | 14.97 |
| 2026-03-11 | SYK | 345.82 | 5.5 | 1051.0 | 14.97 |
| 2026-03-12 | SYK | 337.23 | 5.5 | 1116.4 | 14.97 |
| 2026-03-13 | SYK | 336.81 | 5.5 | 1254.4 | 14.97 |
| 2026-03-17 | SYK | 349.13 | 5.5 | 1254.1 | 14.97 |
| 2026-03-18 | SYK | 345.80 | 5.5 | 1205.6 | 14.97 |
| 2026-03-19 | SYK | 339.68 | 5.5 | 353.4 | 14.97 |
| 2026-03-20 | SYK | 335.67 | 5.5 | -84.4 | 14.97 |
| 2026-03-23 | SYK | 332.66 | 5.5 | -70.8 | 14.97 |
| 2026-03-24 | SYK | 328.51 | 5.5 | -86.2 | 14.97 |
| 2026-03-25 | SYK | 327.58 | 5.5 | -42.2 | 14.97 |
| 2026-03-26 | SYK | 332.70 | 5.5 | 42.7 | 14.97 |
| 2026-03-27 | SYK | 327.43 | 5.5 | -102.5 | 14.97 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | SYK | -4.21 | -0.00 | 1.14 |
| 2026-03-02 | SYK | -4.20 | 0.45 | 1.14 |
| 2026-03-03 | SYK | -4.20 | 0.45 | 1.14 |
| 2026-03-04 | SYK | -4.20 | 0.45 | 1.14 |
| 2026-03-05 | SYK | -4.20 | 0.45 | 1.14 |
| 2026-03-06 | SYK | -4.20 | 0.45 | 1.14 |
| 2026-03-09 | SYK | -4.20 | 0.51 | 1.14 |
| 2026-03-10 | SYK | -4.20 | 0.51 | 1.14 |
| 2026-03-11 | SYK | -4.20 | 0.51 | 1.19 |
| 2026-03-12 | SYK | -4.20 | 0.51 | 1.19 |
| 2026-03-13 | SYK | -4.20 | 0.51 | 1.19 |
| 2026-03-17 | SYK | -4.20 | 0.56 | 1.19 |
| 2026-03-18 | SYK | -4.20 | 0.56 | 1.19 |
| 2026-03-19 | SYK | -4.20 | 0.56 | 1.19 |
| 2026-03-20 | SYK | -4.20 | 0.56 | 1.19 |
| 2026-03-23 | SYK | -4.20 | 0.52 | 1.19 |
| 2026-03-24 | SYK | -4.20 | 0.52 | 1.19 |
| 2026-03-25 | SYK | -4.20 | 0.52 | 1.13 |
| 2026-03-26 | SYK | -4.20 | 0.52 | 1.13 |
| 2026-03-27 | SYK | -4.20 | 0.52 | 1.13 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
4.47
Avg. EPS Est. Current Quarter
3
Avg. EPS Est. Next Quarter
3.46
Insider Transactions
-4.2
Institutional Transactions
0.52
Beta
0.92
Average Sales Estimate Current Quarter
6355
Average Sales Estimate Next Quarter
6566
Fair Value
356.21
Quality Score
88
Growth Score
96
Sentiment Score
46
Actual DrawDown %
19.4
Max Drawdown 5-Year %
-31.7
Target Price
430.92
P/E
38.99
Forward P/E
19.5
PEG
1.75
P/S
4.99
P/B
5.59
P/Free Cash Flow
29.26
EPS
8.4
Average EPS Est. Cur. Y
14.97
EPS Next Y. (Est.)
16.73
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
12.92
Relative Volume
0.86
Return on Equity vs Sector %
-12.9
Return on Equity vs Industry %
2.7
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
-102.5
◆
SYK
Healthcare
$327.44
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
4/20
Pullback
21/25
Volume
4/15
Valuation
18/20
TP/AR
1/10
Options
3/10
RSI
31.1
Range 1M
5%
Sup Dist
0.5%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
10/25
Growth
16/30
Estimates
6/20
Inst/Vol
3/15
Options
7/10
EPS Yr
10.2%
EPS NY
11.9%
52W%
4%
💎
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+15.2% upside
Quality
15/30
Valuation
7/30
Growth
12/25
Stability
6/10
LT Trend
1/5
Upside
+15.2%
Quality
88
MoS
9%
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Medical Devices
Employees: 56000
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
SYK
Latest News
—
Caricamento notizie per SYK…
stock quote shares SYK – Stryker Corporation Stock Price stock today
news today SYK – Stryker Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch SYK – Stryker Corporation yahoo finance google finance
stock history SYK – Stryker Corporation invest stock market
stock prices SYK premarket after hours
ticker SYK fair value insiders trading